MEDCLUERX Trademark

Trademark Overview

On Friday, November 4, 2016, a trademark application was filed for MEDCLUERX with the United States Patent and Trademark Office. The USPTO has given the MEDCLUERX trademark a serial number of 87227362. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, March 22, 2024. This trademark is owned by NorthShore University HealthSystem. The MEDCLUERX trademark is filed in the Pharmaceutical Products category with the following description:

Genomic tests for medical or clinical purposes, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes; genomic tests for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans; kits for use in genetic testing for medical or clinical purposes, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes; kits for use in genetic testing for medical or clinical purposes in DNA testing of humans, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes in DNA testing of humans
medcluerx

General Information

Serial Number87227362
Word MarkMEDCLUERX
Filing DateFriday, November 4, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, March 22, 2024
Registration Number5331220
Registration DateTuesday, November 7, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Description of MarkThe mark consists of the words "MEDCLUE" and a superscript "RX" and three circles located below the superscript "RX".
Goods and ServicesGenomic tests for medical or clinical purposes, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes; genomic tests for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans; kits for use in genetic testing for medical or clinical purposes, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes; kits for use in genetic testing for medical or clinical purposes in DNA testing of humans, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes in DNA testing of humans
Pseudo MarkMED CLUE RX
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"RX"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code005
First Use Anywhere DateThursday, January 12, 2017
First Use In Commerce DateThursday, January 12, 2017

Trademark Owner History

Party NameNorthShore University HealthSystem
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWarrenville, IL 60555
Party NameNorthShore University HealthSystem
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEvanston, IL 60201
Party NameNorthShore University HealthSystem
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEvanston, IL 60201

Trademark Events

Event DateEvent Description
Friday, March 22, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 22, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 27, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 10, 2018REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Wednesday, May 2, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2017REGISTERED-PRINCIPAL REGISTER
Friday, October 6, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 5, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 29, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 7, 2017NON-FINAL ACTION E-MAILED
Thursday, September 7, 2017SU - NON-FINAL ACTION - WRITTEN
Friday, August 25, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, July 31, 2017USE AMENDMENT FILED
Tuesday, August 22, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 31, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 9, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION WRITTEN
Thursday, December 8, 2016ASSIGNED TO EXAMINER
Thursday, November 10, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

medcluerx purposes medical clinical testing genomic kits humans reagents comprised namely